Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Journal of Pharmaceutical and Biomedical Analysis
|
October 30, 2001
Analysis of urinary caffeine metabolites by HPLC-DAD: the use of metabolic ratios to assess CYP1A2 enzyme activity
Marie-Sophie Caubet, Walid Elbast, Marie-Claude Dubuc, et al.
Parkinsonism & Related Disorders
|
August 31, 2014
AQW051, a novel and selective nicotinic acetylcholine receptor α7 partial agonist, reduces l-Dopa-induced dyskinesias and extends the duration of l-Dopa effects in parkinsonian monkeys
Thérèse Di Paolo, Laurent Grégoire, Dominik Feuerbach, et al.
Analytical and Bioanalytical Chemistry
|
June 25, 2014
Laser diode thermal desorption atmospheric pressure chemical ionization tandem mass spectrometry applied for the ultra-fast quantitative analysis of BKM120 in human plasma
Christian Lanshoeft, Olivier Heudi, Luc Alexis Leuthold, et al.
Rapid Communications in Mass Spectrometry : RCM
|
March 13, 2016
Analysis of small molecule antibody-drug conjugate catabolites in rat liver and tumor tissue by liquid extraction surface analysis micro-capillary liquid chromatography/tandem mass spectrometry
Christian Lanshoeft, Gerhard Stutz, Walid Elbast, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
August 3, 2020
A Study of the Effect of Cyclosporine on Fevipiprant Pharmacokinetics and its Absolute Bioavailability Using an Intravenous Microdose Approach
H Markus Weiss, Ken-Ichi Umehara, Veit J Erpenbeck, et al.
Pulmonary Pharmacology & Therapeutics
|
June 14, 2019
Fevipiprant has a low risk of influencing co-medication pharmacokinetics: Impact on simvastatin and rosuvastatin in different SLCO1B1 genotypes
Birk Poller, Ralph Woessner, Avantika Barve, et al.
Clinical Pharmacology in Drug Development
|
June 17, 2016
Pharmacokinetics, Safety, and Tolerability of Fevipiprant (QAW039), a Novel CRTh2 Receptor Antagonist: Results From 2 Randomized, Phase 1, Placebo-Controlled Studies in Healthy Volunteers
Veit J Erpenbeck, Eva Vets, Lien Gheyle, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
April 29, 2016
New Insights in Tissue Distribution, Metabolism, and Excretion of [3H]-Labeled Antibody Maytansinoid Conjugates in Female Tumor-Bearing Nude Rats
Markus Walles, Bettina Rudolph, Thierry Wolf, et al.
Bioanalysis
|
November 22, 2014
European Bioanalysis Forum: recommendation for dealing with internal standard variability
Stephen White, Neil Adcock, Walid Elbast, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Journal of Pharmaceutical and Biomedical Analysis
|
October 30, 2001
Analysis of urinary caffeine metabolites by HPLC-DAD: the use of metabolic ratios to assess CYP1A2 enzyme activity
Marie-Sophie Caubet, Walid Elbast, Marie-Claude Dubuc, et al.
Parkinsonism & Related Disorders
|
August 31, 2014
AQW051, a novel and selective nicotinic acetylcholine receptor α7 partial agonist, reduces l-Dopa-induced dyskinesias and extends the duration of l-Dopa effects in parkinsonian monkeys
Thérèse Di Paolo, Laurent Grégoire, Dominik Feuerbach, et al.
Analytical and Bioanalytical Chemistry
|
June 25, 2014
Laser diode thermal desorption atmospheric pressure chemical ionization tandem mass spectrometry applied for the ultra-fast quantitative analysis of BKM120 in human plasma
Christian Lanshoeft, Olivier Heudi, Luc Alexis Leuthold, et al.
Rapid Communications in Mass Spectrometry : RCM
|
March 13, 2016
Analysis of small molecule antibody-drug conjugate catabolites in rat liver and tumor tissue by liquid extraction surface analysis micro-capillary liquid chromatography/tandem mass spectrometry
Christian Lanshoeft, Gerhard Stutz, Walid Elbast, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
August 3, 2020
A Study of the Effect of Cyclosporine on Fevipiprant Pharmacokinetics and its Absolute Bioavailability Using an Intravenous Microdose Approach
H Markus Weiss, Ken-Ichi Umehara, Veit J Erpenbeck, et al.
Pulmonary Pharmacology & Therapeutics
|
June 14, 2019
Fevipiprant has a low risk of influencing co-medication pharmacokinetics: Impact on simvastatin and rosuvastatin in different SLCO1B1 genotypes
Birk Poller, Ralph Woessner, Avantika Barve, et al.
Clinical Pharmacology in Drug Development
|
June 17, 2016
Pharmacokinetics, Safety, and Tolerability of Fevipiprant (QAW039), a Novel CRTh2 Receptor Antagonist: Results From 2 Randomized, Phase 1, Placebo-Controlled Studies in Healthy Volunteers
Veit J Erpenbeck, Eva Vets, Lien Gheyle, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
April 29, 2016
New Insights in Tissue Distribution, Metabolism, and Excretion of [3H]-Labeled Antibody Maytansinoid Conjugates in Female Tumor-Bearing Nude Rats
Markus Walles, Bettina Rudolph, Thierry Wolf, et al.
Bioanalysis
|
November 22, 2014
European Bioanalysis Forum: recommendation for dealing with internal standard variability
Stephen White, Neil Adcock, Walid Elbast, et al.
Page
of 1